| Term 
 | Definition 
 
        | ○ Administration ○ Liberation
 ○ Absorption
 ○ Distribution
 ○ Metabolism
 ○ Excretion
 |  | 
        |  | 
        
        | Term 
 
        | what is absorbed in stomach? intestines? |  | Definition 
 
        | stomach - weak acids intestine - weak bases
 |  | 
        |  | 
        
        | Term 
 
        | uses of Na-channel blockers? |  | Definition 
 
        | local anesthetics, Anti-arrhythmics, anti-epileptics |  | 
        |  | 
        
        | Term 
 
        | Ester LAs, 1/2 life? metabolism?examples? |  | Definition 
 
        | -short 1/2 life, rapid metabolism by plasma esterases -procaine and cocaine
 |  | 
        |  | 
        
        | Term 
 
        | amide LAs; 1/2 life? metabolism? examples? |  | Definition 
 
        | -longer 1/2 life, hepatic metabolism -lidocaine, etidocaine, prilocaine (2 "i"s in name)
 |  | 
        |  | 
        
        | Term 
 
        | 5 Vaughan-Williams classes of anti-arrhythmics |  | Definition 
 
        | I - Na channel blockers II - beta blockers
 III - K channel blockers
 IV - Ca channel blockers
 V - vagus boosters
 |  | 
        |  | 
        
        | Term 
 
        | VW class IA; action? ex's? |  | Definition 
 
        | decrease pohase 0 and decrease phase 3 can result in tosade de pointe
 quinidine, procainamide, disopyramide
 |  | 
        |  | 
        
        | Term 
 
        | VW class IB; action? ex's? |  | Definition 
 
        | -decrease phase 0 and increase phase 3 -Lidocaine, mexiletine
 |  | 
        |  | 
        
        | Term 
 
        | VW class IC; action? ex's? |  | Definition 
 
        | -decrease phase 0, no effect on phase 3 -flecainide
 |  | 
        |  | 
        
        | Term 
 
        | carbemazipine; type? channel? SEs (and cause)? |  | Definition 
 
        | Anti-epileptic Na channel blocker - membrane stabilization
 CYP P450 3A4 inducer
 SEs (similar to TCA)
 sedation - H1 receptorblocker
 dry mouth - M-receptor blocker
 arrhythmia Na and K channel blocker
 hypotension - alpha-R blocker
 weight gain - 5-HT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ca blockers, statins, macrolide antibiotics, benzodiazepines, HIV antivirals, antihistamines |  | 
        |  | 
        
        | Term 
 
        | Phenytoin; type? channel? SEs? |  | Definition 
 
        | anti-epileptic Na and Ca channel blocker CYP 3A4 inducer 0 order kinetics SEs - gum hyperplasia, megaloblastic anemia, folate/B12 deficiency, peripheral neuropathy, skin rash, hirsuitism |  | 
        |  | 
        
        | Term 
 
        | substrates w/ saturabale hepatic metabolism (zero order kinetics) |  | Definition 
 
        | ethanol, ASA (aspirin), heparin, Theophyllin, phenytoin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | triamterene, dapsone, phenytoin, trimethoprim, methotrexate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Na channel blocker LA ester
 |  | 
        |  | 
        
        | Term 
 
        | lidocaine; channel? type? |  | Definition 
 
        | Na channel blocker LA amide and VW Class IB anti-arrhythmic
 |  | 
        |  | 
        
        | Term 
 
        | quinidine; action? type? SEs? |  | Definition 
 
        | Na channel blocker VW Class IA anti-arrhythmics
 atropine-like effects (anticholinergic)
 SEs - cinchonism (blurred vision, tinnitus, headaches) increased digoxin leves, N & V, arrhythmia
 |  | 
        |  | 
        
        | Term 
 
        | procainamide; action? type? |  | Definition 
 
        | "VW class IA"  technically it is a VW IC (Na blocker only) but is metabolized to NAPA, a VW class III (K-blocker) *fast metabolizers at higher risk for torsades de pointes |  | 
        |  | 
        
        | Term 
 
        | flecainide; action? type? |  | Definition 
 
        | Na channel blocker VW class IC anti-arrhythmic
 |  | 
        |  | 
        
        | Term 
 
        | what causes the following SEs? sedation, dry mouth, arrhythmia, hypotension, weight gain |  | Definition 
 
        | sedation - H1 (histamine) blocker dry mouth - Muscarinic receptor blocker
 arrhythmia - Na or K channel blocker
 Hypotension - Alpha-R blocker
 Weight gain - 5-HT (seratonin)
 |  | 
        |  |